Korea / Samsung Bioepis Goes Down Under; Blockchain-Based Vaccine Certificates; The First Korean Blockbuster?
The latest news from Korean pharma, including how Korea can put the infrastructure in place to develop a homegrown…
Korean Pharmaceutical Association (KPA)
Last updated: 11.11.2014
Korean Pharmaceutical Association (KPA) is a non-profit organization established as Korea Pharmacists Association in 1928. Approximately 60,000 members of KPA have contributed to public health through ‘good quality of medicine and right medication’. With our belief and willingness to improve public health, members of KPA are committed to build a welfare country.
KPA has 16 regional divisions (5 special divisions abroad), 227 branches, General Assembly of Delegates as a legislative body, and 16 standing committees as an executive organization.
KPA has made efforts that pharmacies as the closest health care provider offer good quality of public health care service. KPA has tried to keep the policy of separation of dispensary from medical practice, offer on-going education to pharmacists, renovate and develop pharmacology, improve national health insurance, establish fair trade of medical supplies, promote an information-oriented pharmacology, and build a computerized pharmacy.
In addition, KPA supports various social programs and makes efforts to build social safety networks such as smoking cessation campaign, child protection program, 1388 youth protection campaign, and more.
KPA will try to develop public health service system combining public interests with pharmacists’ right and do the best effort to complete roles of pharmacists under the slogan of ‘pharmacists with pride. KPA in company with public’.
Contact details
Address: 1493-3 Seocho-3 Dong, Seocho-gu, Seoul 137-869 KOREA
Tel: +82 02 581 1201
www.kpanet.or.kr
Related
Joong Myung Cho – Chairman & CEO, CrystalGenomics, South Korea
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…
Young-Shik Cho – Chairman, SD Biosensor
Young-Shik Cho, chairman of SD Biosensor, recounts his journey leading diagnostics companies and expanding their…
Precision Medicine / Reclaiming Asia's Genomic Destiny
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome…
Jeong-Sun Seo – Chairman, Macrogen & President, KoreaBIO
Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO),…
Sangrae Cho – CEO, Gencurix
Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae…
Yeul-Hong Kim – Director, K-MASTER, South Korea
Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data…
M&A / Korean Celltrion Makes First Big Global Move with Acquisition of Takeda APAC Assets
Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the…
SCM Lifescience / A Global Approach to Korean Regenerative Medicine
Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in…
Jisoo Pae – CEO, Genome & Company
Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr…
Rare Diseases / Korean Corestem Targets US Market for Ground-Breaking ALS Treatment
After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea,…
Kyung Suk Kim – CEO, Corestem
Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic…
